{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:28:09Z","timestamp":1773660489517,"version":"3.50.1"},"reference-count":262,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1016\/s0009-8981(02)00301-7","type":"journal-article","created":{"date-parts":[[2002,11,4]],"date-time":"2002-11-04T19:41:17Z","timestamp":1036438877000},"page":"3-25","source":"Crossref","is-referenced-by-count":133,"title":["Neuropeptide Y and its receptors as potential therapeutic drug targets"],"prefix":"10.1016","volume":"326","author":[{"given":"Antonio P","family":"Silva","sequence":"first","affiliation":[]},{"given":"Claudia","family":"Cavadas","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Grouzmann","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0009-8981(02)00301-7_BIB1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y: a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB2","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1073\/pnas.78.7.4175","article-title":"X-ray analysis (1.4\u00c5 resolution) of avian pancreatic polypeptide: small globular protein hormone","volume":"78","author":"Blundell","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.1990.tb48920.x","article-title":"Signal epitopes in the three-dimensional structure of neuropeptide Y","volume":"611","author":"Schwartz","year":"1990","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0301-0082(92)90038-G","article-title":"Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues","volume":"38","author":"Dumont","year":"1992","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1139\/o00-004","article-title":"Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution","volume":"78","author":"Cerda-Reverter","year":"2000","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(94)91306-4","article-title":"Intracerebroventricular injection of dibutyryl cyclic adenosine 3\u2032,5\u2032-monophosphate increases hypothalamic levels of neuropeptide Y","volume":"660","author":"Akabayashi","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/bj3330505","article-title":"Stimulation of neuropeptide Y gene expression by brain-derived neurotrophic factor requires both the phospholipase Cgamma and Shc binding sites on its receptor, TrkB","volume":"333","author":"Williams","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB8","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1016\/S0021-9258(18)68784-8","article-title":"Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester","volume":"263","author":"Higuchi","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB9","doi-asserted-by":"crossref","unstructured":"Palkovits M. Peptidergic neurotransmitters in the endocrine hypothalamus. In: Ciba Foundation Symposia, editor, Functional anatomy of the neuroendocrine hypothalamus. Chichester: Wiley; 1992. p. 3\u201315.","DOI":"10.1002\/9780470514283.ch2"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/er.20.1.68","article-title":"Interacting appetite-regulating pathways in the hypothalamic regulation of body weight","volume":"20","author":"Kalra","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB11","series-title":"PP, PYY, and NPY. Occurrence and distribution in the periphery","first-page":"157","author":"Sundler","year":"1993"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB12","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1210\/jc.86.12.5956","article-title":"NPY regulates catecholamine secretion from human adrenal chromaffin cells","volume":"86","author":"Cavadas","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0167-0115(95)00114-5","article-title":"Neuropeptide Y is expressed in subpopulations of insulin- and non-insulin-producing islet cells in the rat after dexamethasone treatment: a combined immunocytochemical and in situ hybridisation study","volume":"60","author":"Myrsen","year":"1995","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB14","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2337\/diabetes.45.10.1306","article-title":"Dexamethasone-induced neuropeptide Y expression in rat islet endocrine cells. Rapid reversibility and partial prevention by insulin","volume":"60","author":"Myrsen","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB15","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1073\/pnas.84.16.5585","article-title":"Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice","volume":"84","author":"Ericsson","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB16","series-title":"Neuropeptides: regulators of physiological processes","author":"Strand","year":"1999"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB17","first-page":"143","article-title":"XVI International Union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors","volume":"50","author":"Michel","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB18","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1016\/S0021-9258(19)49854-2","article-title":"Cloning and functional expression of a human neuropeptide Y\/peptide YY receptor of the Y1 type","volume":"267","author":"Larhammar","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB19","doi-asserted-by":"crossref","first-page":"22661","DOI":"10.1074\/jbc.270.39.22661","article-title":"Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor","volume":"270","author":"Rose","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB20","doi-asserted-by":"crossref","first-page":"29123","DOI":"10.1074\/jbc.270.49.29123","article-title":"Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY","volume":"270","author":"Lundell","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/382168a0","article-title":"A receptor subtype involved in neuropeptide Y-induced food intake","volume":"382","author":"Gerald","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB22","doi-asserted-by":"crossref","first-page":"16435","DOI":"10.1074\/jbc.271.28.16435","article-title":"Cloning and expression of a novel neuropeptide Y receptor","volume":"271","author":"Weinberg","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB23","first-page":"817","article-title":"Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor","volume":"41","author":"Krause","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB24","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1046\/j.1432-1327.2001.02161.x","article-title":"Novel analogues of neuropeptide Y with a preference for the Y1-receptor","volume":"268","author":"Soll","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E","article-title":"Molecular characterization of the ligand\u2013receptor interaction of the neuropeptide Y family","volume":"6","author":"Cabrele","year":"2000","journal-title":"J. Pept. Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB26","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1073\/pnas.92.20.9067","article-title":"High affinity neuropeptide Y receptor antagonists","volume":"92","author":"Daniels","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0196-9781(97)00455-5","article-title":"The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist gor the human pancreatic polypeptide-preferring (NPY Y4) receptor","volume":"19","author":"Schober","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(98)00171-X","article-title":"GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists","volume":"349","author":"Parker","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB29","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0014-2999(94)90822-2","article-title":"The first highly potent and selective non-peptide neuropeptide Y Y1 antagonist: BIBP3226","volume":"271","author":"Rudolf","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0014-5793(95)00230-7","article-title":"SR120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist","volume":"362","author":"Serradeil-Le","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bjp.0702084","article-title":"Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO3304 and its effect on feeding in rodents","volume":"125","author":"Wieland","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB32","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/jm970512x","article-title":"Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists","volume":"40","author":"Hipskind","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB33","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1021\/jm990044m","article-title":"1,3-Disubstituted benzodiazepines as novel, potent, selective neuropeptide Y Y1 receptor antagonists","volume":"42","author":"Murakami","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/mol.59.3.501","article-title":"A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814","volume":"59","author":"Kanatani","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(01)00919-0","article-title":"Pharmacology of H 394\/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo","volume":"418","author":"Malmstrom","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/10799899909036659","article-title":"Comparison of antibodies directed against receptor segments of NPY-receptors","volume":"19","author":"Eckard","year":"1999","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB37","first-page":"85","article-title":"Effects of neuropeptide Y (NPY) at the synaptic neuroeffector junction. Can pre- and postjunctional receptors be distinguished?","volume":"64","author":"Wahlestedt","year":"1986","journal-title":"Med. Biol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1476-5381.1992.tb14208.x","article-title":"Characterization of vascular neuropeptide Y receptors","volume":"105","author":"Grundemar","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB39","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.8380941","article-title":"Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligonucleotides","volume":"259","author":"Wahlestedt","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0166-2236(98)01292-2","article-title":"Feeding and body-weight regulation by hypothalamic neuropeptides\u2014mediation of the actions of leptin","volume":"22","author":"Inui","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-5793(90)80069-U","article-title":"Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase","volume":"15","author":"Aakerlund","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-5793(96)00943-X","article-title":"Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor","volume":"394","author":"Rist","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB43","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjp.0702388","article-title":"Influence of TASP-V, a novel neuropeptide Y\/NPY Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans","volume":"126","author":"Malis","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB44","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1074\/jbc.272.12.7699","article-title":"Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. Synthesis and pharmacological evaluation of a Y2 antagonist","volume":"272","author":"Grouzmann","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB45","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(99)00650-0","article-title":"BIIE0246: a selective and high affinity neuropeptide Y Y2 receptor antagonist","volume":"384","author":"Doods","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/bbrc.1998.8647","article-title":"Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon","volume":"247","author":"Goumain","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.RES.83.2.187","article-title":"Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium","volume":"83","author":"Zukowska-Grojec","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(97)89656-2","article-title":"The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y","volume":"327","author":"Pheng","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB49","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1432-1033.1992.tb17006.x","article-title":"A novel cyclic analog of neuropeptide Y specific for the Y2 receptor","volume":"206","author":"Beck-Sickinger","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB50","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.1016\/S0021-9258(17)37183-1","article-title":"A pertussis toxin-insensitive calcium influx mediated by neuropeptide Y2 receptors in a human neuroblastoma cell line","volume":"269","author":"Lynch","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB51","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1016\/S0021-9258(17)37045-X","article-title":"Y2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line","volume":"269","author":"Shigeri","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-0115(98)00054-8","article-title":"Is there really an NPY Y3 receptor?","volume":"75\/76","author":"Lee","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0196-9781(90)90057-C","article-title":"Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes","volume":"11","author":"Balasubramaniam","year":"1990","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB54","doi-asserted-by":"crossref","first-page":"PL7","DOI":"10.1016\/0024-3205(92)90342-M","article-title":"Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y\/peptide YY","volume":"50","author":"Wahlestedt","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-2999(93)90502-9","article-title":"Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types","volume":"238","author":"Dumont","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0169-328X(94)90105-8","article-title":"Peptide YY derivatives as selective neuropeptide Y\/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type","volume":"26","author":"Dumont","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00169073","article-title":"Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase\/protein kinase A system","volume":"351","author":"Norenberg","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB58","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1073\/pnas.93.10.5111","article-title":"The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor","volume":"93","author":"Lundell","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB59","doi-asserted-by":"crossref","first-page":"26762","DOI":"10.1074\/jbc.270.45.26762","article-title":"Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY","volume":"270","author":"Bard","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB60","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0016-5085(83)80027-4","article-title":"Pancreatic polypeptide: a hormone under vagal control","volume":"85","author":"Schwartz","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB61","first-page":"2274","article-title":"Gallbladder motility and cholecystokinin secretion during continuous enteral nutrition","volume":"92","author":"Ledeboer","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB62","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1210\/en.140.11.5171","article-title":"Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors","volume":"140","author":"Jain","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB63","first-page":"638","article-title":"Functional and molecular properties of the human recombinant Y4 receptor: resistance to agonist-promoted desensitization","volume":"292","author":"Voisin","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(98)00052-4","article-title":"Molecular biology and pharmacology of multiple NPY Y5 receptor species homologs","volume":"75\u201376","author":"Borowsky","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB65","doi-asserted-by":"crossref","first-page":"36043","DOI":"10.1074\/jbc.M000626200","article-title":"The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats","volume":"275","author":"Cabrele","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB66","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI4188","article-title":"Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor","volume":"102","author":"Criscione","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB67","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.ijo.0801472","article-title":"Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade","volume":"25","author":"Della Zuana","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB68","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0960-894X(00)00311-5","article-title":"N-acetylated alpha-(3-pyridylmethyl)-beta-aminotetralin antagonists of the human neuropeptide Y Y5 receptor","volume":"10","author":"McNally","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/bbrc.2000.2696","article-title":"L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist","volume":"272","author":"Kanatani","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB70","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/382168a0","article-title":"A receptor subtype involved in neuropeptide-Y-induced food intake","volume":"382","author":"Gerald","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1139\/y99-125","article-title":"Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells","volume":"78","author":"Moser","year":"2000","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(89)90403-4","article-title":"Presynaptic inhibition by neuropeptide Y and baclofen in hippocampus: insensitivity to pertussis toxin treatment","volume":"498","author":"Colmers","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB73","first-page":"H1727","article-title":"Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes","volume":"261","author":"Millar","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB74","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/BF00373890","article-title":"Neuropeptide Y2-type receptor-mediated activation of large-conductance Ca(2+)-sensitive K+ channels in a human neuroblastoma cell line","volume":"430","author":"Lemos","year":"1995","journal-title":"Pfl\u00fcgers Arch."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0079-6123(08)60249-6","article-title":"Neuropeptide Y receptor interaction with beta-adrenoceptor coupling to adenylate cyclase","volume":"68","author":"Olasmaa","year":"1986","journal-title":"Prog. Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0165-6147(91)90610-5","article-title":"Receptors for neuropeptideY: multiple subtypes and multiple second messengers","volume":"12","author":"Michel","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB77","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1016\/S0021-9258(18)83236-7","article-title":"Two different G-proteins mediate neuropeptide Y and bradykinin-stimulated phospholipid breakdown in cultured rat sensory neurons","volume":"264","author":"Perney","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB78","first-page":"E880","article-title":"Neuropeptide Y mobilizes Ca2+ and inhibits adenylate cyclase in human erythroleukemia cells","volume":"255","author":"Motulsky","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB79","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1073\/pnas.85.10.3633","article-title":"Guanine nucleotide-binding protein Go-induced coupling of neuropeptide Y receptors to Ca2+ channels in sensory neurons","volume":"85","author":"Ewald","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0006-8993(90)90967-G","article-title":"Modulation by neuropeptides of bradykinin-stimulated second messenger release in dorsal root ganglion neurons","volume":"518","author":"Gammon","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB81","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00004872-199504000-00003","article-title":"Neuropeptide Y: a possible role in hypertension?","volume":"13","author":"Michel","year":"1995","journal-title":"J. Hypertens."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB82","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF00374383","article-title":"ATP-dependent inhibition of Ca2+-activated K+ channels in vascular smooth muscle cells by neuropeptide Y","volume":"431","author":"Xiong","year":"1995","journal-title":"Pfl\u00fcgers Arch."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB83","first-page":"H927","article-title":"Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers","volume":"257","author":"Martin","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-291X(91)91370-R","article-title":"Neuropeptide Y stimulates prostacyclin production in porcine vascular endothelial cells","volume":"179","author":"Kawamura","year":"1991","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB85","first-page":"1172","article-title":"Neuropeptide Y stimulation of extracellular signal-regulated kinases in human erythroleukemia cells","volume":"291","author":"Keffel","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0773.1995.tb01913.x","article-title":"Relation between cyclic GMP generation and cerebrovascular reactivity: modulation by NPY and \u03b1-trinositol","volume":"77","author":"You","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB87","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1139\/y99-148","article-title":"Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent","volume":"78","author":"Nilsson","year":"2000","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB88","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0167-0115(98)00083-4","article-title":"NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines bearing Y1 and Y2 receptors: involvement of CREB","volume":"75\u201376","author":"Sheriff","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB89","first-page":"517","article-title":"A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance","volume":"19","author":"Rohner-Jeanrenaud","year":"1995","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/2164","article-title":"Unraveling the central nervous system pathways underlying responses to leptin","volume":"1","author":"Elmquist","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB91","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0896-6273(00)81084-3","article-title":"From lesions to leptin: hypothalamic control of food intake and body weight","volume":"22","author":"Elmquist","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB92","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-6147(99)01303-6","article-title":"Neuropeptide Y feeding receptors: are multiple subtypes involved?","volume":"20","author":"Inui","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(87)90004-9","article-title":"The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism","volume":"28","author":"Luiten","year":"1987","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB94","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0300-595X(84)80036-5","article-title":"Integration of energy intake and expenditure in animals and man: the autonomic and adrenal hypothesis","volume":"13","author":"Bray","year":"1984","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB95","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1517\/13543784.9.6.1327","article-title":"The role of NPY in metabolic homeostasis: implications for obesity therapy","volume":"9","author":"Wieland","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB96","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(00)80934-4","article-title":"Appetite and body weight regulation: is it all in the brain?","volume":"19","author":"Kalra","year":"1997","journal-title":"Neuron"},{"issue":"457","key":"10.1016\/S0009-8981(02)00301-7_BIB97","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0006-8993(88)90710-X","article-title":"Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior","volume":"9","author":"Sahu","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB98","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/0196-9781(88)90191-X","article-title":"Bilateral neural transections at the level of mesencephalon increase food intake and reduce latency to onset of feeding in response to neuropeptide Y","volume":"9","author":"Sahu","year":"1988","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB99","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/endo-115-1-427","article-title":"Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats","volume":"115","author":"Clark","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB100","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0196-9781(86)90149-X","article-title":"Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity","volume":"7","author":"Stanley","year":"1986","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB101","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0196-9781(92)90093-I","article-title":"Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect","volume":"13","author":"Stanley","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB102","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/jc.84.10.3781","article-title":"Activation of central neuropeptide Y Y1 receptors potently stimulates food intake in male rhesus monkeys","volume":"84","author":"Larsen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB103","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0303-7207(01)00620-7","article-title":"Chronic administration of neuropeptide Y into the lateral ventricle of C57BL\/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism","volume":"185","author":"Raposinho","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0196-9781(88)90013-7","article-title":"Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus","volume":"9","author":"Sahu","year":"1988","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB105","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0024-3205(91)90049-H","article-title":"Hypothalamic neuropeptide Y receptor characteristics and NPY-induced feeding responses in lean and obese Zucker rats","volume":"49","author":"McCarthy","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB106","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(95)00628-4","article-title":"Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa\/fa) Zucker rats","volume":"690","author":"Dryden","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB107","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/377530a0","article-title":"The role of neuropeptide Y in the antiobesity action of the obese gene product","volume":"377","author":"Stephens","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB108","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0006-8993(97)00160-1","article-title":"Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 \u2018feeding\u2019 receptor","volume":"758","author":"Widdowson","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB109","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/BF00399793","article-title":"Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats","volume":"37","author":"Vettor","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000126972","article-title":"Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats","volume":"63","author":"Sainsbury","year":"1996","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB111","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-8993(94)90103-1","article-title":"Evidence that neuropeptide Y is a physiological signal for normal food intake","volume":"646","author":"Dube","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB112","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0006-8993(97)00192-3","article-title":"Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes","volume":"755","author":"Sahu","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB113","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/diabetes.45.4.531","article-title":"Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob\/ob mice","volume":"45","author":"Schwartz","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB114","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/endo-126-2-765","article-title":"Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats","volume":"126","author":"White","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/381415a0","article-title":"Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y","volume":"381","author":"Erickson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB116","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1172\/JCI118891","article-title":"Identification of targets of leptin action in rat hypothalamus","volume":"98","author":"Schwartz","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB117","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0196-9781(92)90178-6","article-title":"Insulin deficiency is a specific stimulus to hypothalamic neuropeptide Y: a comparison of the effects of insulin replacement and food restriction in streptozocin-diabetic rats","volume":"13","author":"McKibbin","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB118","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0167-0115(98)00088-3","article-title":"Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?","volume":"75\u201376","author":"Haynes","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB119","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/sj.bjp.0701969","article-title":"Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226","volume":"124","author":"Kask","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0196-9781(01)00359-X","article-title":"Feeding after fourth ventricular administration of neuropeptide Y receptor agonists in rats","volume":"22","author":"Corpa","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB121","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1210\/en.137.8.3177","article-title":"Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake","volume":"137","author":"Kanatani","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB122","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0167-0115(98)00096-2","article-title":"NPY-induced feeding involves the action of a Y1-like receptor in rodents","volume":"75\u201376","author":"Kanatani","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB123","first-page":"R1500","article-title":"A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats","volume":"274","author":"Ishihara","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB124","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0196-9781(99)00044-3","article-title":"Hypothalamic NPY status during positive energy balance and the effects of the NPY antagonist, BW 1229U91, on the consumption of highly palatable energy-rich diet","volume":"20","author":"Widdowson","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB125","first-page":"1031","article-title":"Characterization of neuropeptide Y-induced feeding in mice: do Y1\u2013y6 receptor","volume":"289","author":"Iyengar","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-0115(97)01044-6","article-title":"Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors","volume":"72","author":"Matthews","year":"1997","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB127","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0167-0115(98)00091-3","article-title":"The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism","volume":"75\u201376","author":"Morgan","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0196-9781(99)00170-9","article-title":"Neuropeptide Y receptor(s) mediating feeding in the rat: characterization with antagonists","volume":"21","author":"Polidori","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/bbrc.1999.1750","article-title":"The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability","volume":"266","author":"Kanatani","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB130","first-page":"R1428","article-title":"Activation of the NPY Y5 receptor regulates both feeding and energy expenditure","volume":"277","author":"Hwa","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB131","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1097\/00001756-199808030-00046","article-title":"Stimulation of feeding in lean but not in obese Zucker rats by a selective neuropeptide Y Y5 receptor agonist","volume":"9","author":"Wyss","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB132","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0196-9781(00)00156-X","article-title":"[d-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake","volume":"21","author":"Parker","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB133","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.2337\/diabetes.46.11.1792","article-title":"Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides","volume":"46","author":"Schaffhauser","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB134","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1677\/joe.0.1590307","article-title":"Entral administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y","volume":"159","author":"Tang-Christensen","year":"1998","journal-title":"J. Endocrinol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-2999(01)00768-3","article-title":"Neuropeptide Y Y(5) receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat","volume":"414","author":"Kask","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB136","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0167-0115(02)00034-4","article-title":"Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist","volume":"106","author":"Daniels","year":"2002","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB137","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0149-7634(01)00003-3","article-title":"KO's and organisation of peptidergic feeding behavior mechanisms","volume":"25","author":"Beck","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB138","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0167-0115(98)00092-5","article-title":"Response of neuropeptide Y-deficient mice to feeding effectors","volume":"75\u201376","author":"Hollopeter","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB139","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-8993(00)02285-X","article-title":"Behavioral characterization of neuropeptide Y knockout mice","volume":"868","author":"Bannon","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB140","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nm0698-722","article-title":"Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor","volume":"4","author":"Pedrazzini","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB141","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm0698-718","article-title":"Role of the Y5 neuropeptide Y receptor in feeding and obesity","volume":"4","author":"Marsh","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB142","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archpsyc.1990.01810180048008","article-title":"Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa","volume":"47","author":"Kaye","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB143","first-page":"356","article-title":"Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa","volume":"22","author":"Baranowska","year":"2001","journal-title":"Neuro endocrinol. Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB144","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1748-1716.1983.tb07261.x","article-title":"Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat","volume":"118","author":"Fuxe","year":"1983","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0167-0115(87)90278-3","article-title":"Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat","volume":"19","author":"Heilig","year":"1987","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB146","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.1993.35","article-title":"Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects","volume":"8","author":"Heilig","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB147","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/REVNEURO.2002.13.1.85","article-title":"Brain neuropeptide Y (NPY) in stress and alcohol dependence","volume":"13","author":"Heilig","year":"2002","journal-title":"Rev. Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB148","first-page":"171","article-title":"Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y","volume":"11","author":"Inui","year":"1998","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB149","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1046\/j.0953-816x.2001.01601.x","article-title":"Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism","volume":"13","author":"Naveilhan","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008877-199504000-00001","article-title":"Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures","volume":"6","author":"Broqua","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB151","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0167-0115(95)00103-I","article-title":"Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding","volume":"59","author":"Heilig","year":"1995","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB152","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0306-4522(01)00116-6","article-title":"Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety","volume":"104","author":"Kask","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB153","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(99)00018-7","article-title":"Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test","volume":"368","author":"Sajdyk","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB154","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0028-3908(00)00057-5","article-title":"Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men","volume":"39","author":"Antonijevic","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-2236(98)01284-3","article-title":"Neuropeptide Y: emerging evidence for a functional role in seizure modulation","volume":"22","author":"Vezzani","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB156","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0306-4522(92)90207-I","article-title":"Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat","volume":"50","author":"Sperk","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB157","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1471-4159.1991.tb08181.x","article-title":"Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures","volume":"56","author":"Bellmann","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB158","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1460-9568.1993.tb00222.x","article-title":"Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons","volume":"5","author":"Rizzi","year":"1993","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB159","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hipo.450040409","article-title":"Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection","volume":"4","author":"Gruber","year":"1994","journal-title":"Hippocampus"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-0173(96)00005-7","article-title":"Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis","volume":"22","author":"Schwarzer","year":"1996","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB161","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1113\/jphysiol.1987.sp016409","article-title":"Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice","volume":"383","author":"Colmers","year":"1987","journal-title":"J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB162","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1476-5381.1991.tb12129.x","article-title":"Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor","volume":"102","author":"Colmers","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB163","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cne.902570207","article-title":"Action and location of neuropeptide tyrosine (Y) on hippocampal neurons of the rat in slice preparations","volume":"257","author":"Haas","year":"1987","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB164","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1476-5381.1994.tb17055.x","article-title":"Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro","volume":"113","author":"Greber","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB165","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1152\/jn.1999.82.1.478","article-title":"NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus","volume":"82","author":"Patrylo","year":"1999","journal-title":"J. Neurophysiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB166","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0196-9781(01)00347-3","article-title":"Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation","volume":"22","author":"Reibel","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB167","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1523\/JNEUROSCI.17-23-08927.1997","article-title":"Knock-out mice reveal a critical antiepileptic role for neuropeptide Y","volume":"17","author":"Baraban","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB168","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(00)01137-X","article-title":"Experimentally induced attenuation of neuropeptide-Y gene expression in transgenic mice increases mortality rate following seizures","volume":"287","author":"DePrato Primeaux","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB169","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0306-4522(01)00581-4","article-title":"Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y","volume":"110","author":"Vezzani","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(97)00492-8","article-title":"Altered expression of NPY-Y1 receptors in kainic acid induced epilepsy in rats","volume":"230","author":"Kofler","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB171","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0006-8993(97)01012-3","article-title":"Reduction of neuropeptide Y binding sites in the rat hippocampus after electroconvulsive stimulations","volume":"776","author":"Greisen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB172","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1098-1063(1998)8:3<274::AID-HIPO9>3.0.CO;2-J","article-title":"Glutamate-stimulated neuropeptide Y mRNA expression in the rat dentate gyrus: a prominent role of metabotropic glutamate receptors","volume":"8","author":"Schwarzer","year":"1998","journal-title":"Hippocampus"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB173","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0306-4522(00)00078-6","article-title":"Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus","volume":"98","author":"Madsen","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB174","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(00)00162-7","article-title":"Decreased levels of neuropeptide Y(5) receptor binding sites in two experimental models of epilepsy","volume":"98","author":"Bregola","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB175","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1523\/JNEUROSCI.21-15-05804.2001","article-title":"Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy","volume":"21","author":"Furtinger","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB176","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1152\/jn.1997.78.3.1651","article-title":"Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro","volume":"78","author":"Klapstein","year":"1997","journal-title":"J. Neurophysiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB177","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1471-4159.2001.00560.x","article-title":"Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus","volume":"79","author":"Silva","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB178","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0167-0115(98)00079-2","article-title":"Antiepileptic effects of NPY on pentylenetetrazole seizures","volume":"75\u201376","author":"Woldbye","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB179","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nm0797-761","article-title":"Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors","volume":"3","author":"Woldbye","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB180","doi-asserted-by":"crossref","first-page":"13518","DOI":"10.1073\/pnas.96.23.13518","article-title":"Role of the Y5 neuropeptide Y receptor in limbic seizures","volume":"96","author":"Marsh","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB181","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1152\/jn.2000.83.2.723","article-title":"Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices","volume":"83","author":"Ho","year":"2000","journal-title":"J. Neurophysiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB182","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1460-9568.1998.00061.x","article-title":"Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors","volume":"10","author":"Gariboldi","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB183","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.1979.59.3.449","article-title":"Neural regulation of circadian rhythms","volume":"59","author":"Rusak","year":"1979","journal-title":"Physiol. Rev."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB184","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1126\/science.2305266","article-title":"Transplanted suprachiasmatic nucleus determines circadian period","volume":"247","author":"Ralph","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3940(88)90217-0","article-title":"Neuropeptide Y localization in the rat suprachiasmatic nucleus and periventricular hypothalamus","volume":"88","author":"Card","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB186","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1749-6632.1990.tb48935.x","article-title":"Ultrastructural localization of neuropeptide Y in the hypothalamus","volume":"611","author":"Pelletier","year":"1990","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB187","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cne.903570408","article-title":"Organization of permanent and transient neuropeptide Y-immunoreactive neuron groups and fiber systems in the developing hamster diencephalon","volume":"357","author":"Botchkina","year":"1995","journal-title":"Comp. Neurol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB188","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0091-3057(94)90332-8","article-title":"Neuropeptide Y: intrastriatal injections produce contralateral circling that is blocked by a dopamine antagonist in rats","volume":"48","author":"Moore","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB189","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0361-9230(85)90037-1","article-title":"Neuropeptide Y immunoreactivity in the hamster geniculo-suprachiasmatic tract","volume":"15","author":"Harrington","year":"1985","journal-title":"Brain Res. Bull."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB190","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0196-9781(01)00356-4","article-title":"Neuropeptide Y in the mammalian circadian system: effects on light-induced circadian responses","volume":"22","author":"Yannielli","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB191","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(93)91118-C","article-title":"Neuropeptide Y and optic chiasm stimulation affect suprachiasmatic nucleus circadian function in vitro","volume":"615","author":"Shibata","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB192","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0306-4522(94)90331-X","article-title":"Neuropeptide Y and behaviorally induced phase shifts","volume":"62","author":"Biello","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB193","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0196-9781(94)90126-0","article-title":"Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness","volume":"15","author":"Huhman","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB194","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/00001756-199605170-00005","article-title":"Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor","volume":"7","author":"Huhman","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB195","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/00001756-199605170-00020","article-title":"Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor","volume":"7","author":"Golombek","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB196","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1523\/JNEUROSCI.18-08-03014.1998","article-title":"Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes","volume":"18","author":"Gribkoff","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB197","doi-asserted-by":"crossref","first-page":"15211","DOI":"10.1073\/pnas.96.26.15211","article-title":"Rapid down-regulation of mammalian period genes during behavioral resetting of the circadian clock","volume":"96","author":"Maywood","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB198","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3940(01)02304-7","article-title":"Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus","volume":"314","author":"Fukuhara","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB199","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-8993(87)91297-2","article-title":"Modulation of memory processing by neuropeptide Y","volume":"421","author":"Flood","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB200","first-page":"1010","article-title":"Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice","volume":"268","author":"Nakajima","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB201","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0196-9781(89)90176-9","article-title":"Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation","volume":"10","author":"Flood","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB202","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1073\/pnas.220232997","article-title":"Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression","volume":"97","author":"Thorsell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB203","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00003495-199652030-00004","article-title":"The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive","volume":"52","author":"Munglani","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB204","first-page":"243","article-title":"The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure\u2013activity relationship","volume":"258","author":"Hua","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0306-4522(91)90092-3","article-title":"Microinjection of neuropeptide Y into the superficial dorsal horn reduces stimulus-evoked release of immunoreactive substance P in the anaesthetized cat","volume":"4","author":"Duggan","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB206","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-8993(94)01265-J","article-title":"Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y","volume":"669","author":"Tracey","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB207","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/35054063","article-title":"Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor","volume":"409","author":"Naveilhan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB208","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-8993(96)01340-6","article-title":"Intrathecal neuropeptide Y exacerbates nerve injury-induced mechanical hyperalgesia","volume":"750","author":"White","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB209","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/0024-3205(96)00244-5","article-title":"Effect on nociception of intracerebroventricular administration of low doses of neuropeptide Y in mice","volume":"58","author":"Mellado","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(96)00262-4","article-title":"Antinociceptive effects of neuropeptide Y and related peptides in mice","volume":"724","author":"Broqua","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB211","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0167-0115(00)00165-8","article-title":"Involvement of neuropeptide Y and Y1 receptor in antinociception in nucleus raphe magnus of rats","volume":"95","author":"Zhang","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB212","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0006-8993(99)02408-7","article-title":"Antinociceptive effects induced by intra-periaqueductal grey administration of neuropeptide Y in rats","volume":"859","author":"Wang","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0006-8993(02)02594-5","article-title":"Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect","volume":"940","author":"Li","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB214","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(93)90773-E","article-title":"Centrally administered neuropeptide Y fails to increase food intake but enhances hypoalgesia in spontaneously hypertensive rats","volume":"149","author":"Pich","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB215","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0196-9781(00)00270-9","article-title":"The rewarding properties of neuropeptide Y in perifornical hypothalamus vs. nucleus accumbens","volume":"21","author":"Brown","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB216","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1530-0277.2001.tb02162.x","article-title":"Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats","volume":"25","author":"Caberlotto","year":"2001","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB217","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1097\/00001756-200011090-00023","article-title":"Acute ethanol decreases NPY mRNA but not POMC mRNA in the arcuate nucleus","volume":"11","author":"Kinoshita","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB218","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/24614","article-title":"Ethanol consumption and resistance are inversely related to neuropeptide Y levels","volume":"396","author":"Thiele","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB219","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1096-8628(20000717)93:2<117::AID-AJMG7>3.0.CO;2-#","article-title":"Neuropeptide Y polymorphism and alcohol consumption in middle-aged men","volume":"93","author":"Kauhanen","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB220","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0091-3057(00)00413-5","article-title":"Neurobiological responses to ethanol in mutant mice lacking neuropeptide Y or the Y5 receptor","volume":"67","author":"Thiele","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"RC208","key":"10.1016\/S0009-8981(02)00301-7_BIB221","first-page":"1","article-title":"Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor","volume":"22","author":"Thiele","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB222","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0196-9781(01)00361-8","article-title":"Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration","volume":"22","author":"Kelley","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB223","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0091-3057(00)00215-X","article-title":"Increases in sucrose consumption, but not ethanol consumption, following ICV NPY administration","volume":"66","author":"Slawecki","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB224","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00213-001-0950-9","article-title":"Neuropeptide Y administration into the third ventricle does not increase sucrose or ethanol self-administration but does affect the cortical EEG and increases food intake","volume":"160","author":"Katner","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB225","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1530-0277.2001.tb02225.x","article-title":"Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats","volume":"25","author":"Badia-Elder","year":"2001","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB226","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1096\/fj.00-0436fje","article-title":"Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans","volume":"15","author":"Kallio","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB227","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0306-3623(91)90235-X","article-title":"The effects of chronic administration of morphine on the levels of brain and adrenal catecholamines and neuropeptide Y","volume":"22","author":"Pages","year":"1991","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB228","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0306-3623(92)90003-3","article-title":"Brain and adrenal monoamines and neuropeptide Y in codeine tolerant rats","volume":"23","author":"Pages","year":"1992","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB229","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/syn.890190307","article-title":"Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus","volume":"19","author":"Holmes","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB230","first-page":"633","article-title":"Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors","volume":"284","author":"Woldbye","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB231","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1748-1716.1982.tb07157.x","article-title":"Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade","volume":"116","author":"Lundberg","year":"1982","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB232","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0196-9781(92)90004-M","article-title":"A sensitive and specific two-site, sandwich-amplified enzyme immunoassay for neuropeptide Y","volume":"13","author":"Grouzmann","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB233","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1748-1716.1995.tb09981.x","article-title":"Endogenous NPY acting on the Y1 receptor accounts for the long-lasting part of the sympathetic contraction in guinea-pig vena cava: evidence using SR 120107A","volume":"155","author":"Malmstrom","year":"1995","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB234","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0014-2999(95)00606-0","article-title":"Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435","volume":"294","author":"Malmstrom","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB235","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1111\/j.1476-5381.1995.tb15952.x","article-title":"Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226","volume":"116","author":"Lundberg","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB236","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0196-9781(97)00297-0","article-title":"Role of neuropeptide Y in cold stress-induced hypertension","volume":"19","author":"Han","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB237","first-page":"735","article-title":"Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action","volume":"234","author":"Wahlestedt","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00242-8","article-title":"Neuropeptide Y Y1 receptors in vascular pharmacology","volume":"349","author":"Franco-Cereceda","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB239","first-page":"H760","article-title":"Human neuropeptide Y potentiates alpha1-adrenergic blood pressure responses in vivo","volume":"275","author":"Schuerch","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB240","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.bjp.0704171","article-title":"Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y2 receptor antagonist, in vivo","volume":"133","author":"Malmstr\u00f6m","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB241","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/0024-3205(87)90442-5","article-title":"Markedly reduced blood pressure responsiveness in endotoxemic rats: reversal by neuropeptide Y","volume":"41","author":"Evequoz","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB242","first-page":"H1416","article-title":"Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock","volume":"265","author":"Hauser","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB243","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1677\/joe.0.1160421","article-title":"Plasma levels of neuropeptide tyrosine Y (NPY) are increased in human sepsis but are unchanged during canine endotoxin shock despite raised catecholamine concentrations","volume":"116","author":"Watson","year":"1988","journal-title":"J. Endocrinol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB244","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0024-3205(94)00416-P","article-title":"Changes in plasma concentrations of vasoactive neuropeptides in patients with sepsis and septic shock","volume":"56","author":"Arnalich","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0167-0115(98)00071-8","article-title":"Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock","volume":"75\u201376","author":"Qureshi","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB246","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1474-8673.1994.tb00601.x","article-title":"Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release","volume":"14","author":"Takiyyuddin","year":"1994","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB247","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0196-9781(85)90456-5","article-title":"Co-localization of neuropeptide tyrosine (NPY) and its C-terminal flanking peptide (C-PON)","volume":"6","author":"Gulbenkian","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB248","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0167-0115(86)90224-7","article-title":"Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients","volume":"13","author":"Lundberg","year":"1986","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB249","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0196-9781(87)90168-9","article-title":"Immunohistochemical studies for multiple peptide-immunoreactivities and co-localization of Met-enkephalin-Arg6-Gly7-Leu8, neuropeptide Y and somatostatin in human adrenal medulla and pheochromocytomas","volume":"8","author":"Osamura","year":"1987","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB250","first-page":"468","article-title":"Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells","volume":"244","author":"Higuchi","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB251","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0197-0186(93)90145-U","article-title":"Antiserum against neuropeptide Y enhances the nicotine-mediated release of catecholamines from cultured rat adrenal chromaffin cells","volume":"23","author":"Shimoda","year":"1993","journal-title":"Neurochem. Int."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB252","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0143-4179(89)90019-X","article-title":"Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y","volume":"13","author":"Hexum","year":"1989","journal-title":"Neuropeptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB253","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1124\/mol.52.6.1027","article-title":"Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process","volume":"52","author":"Zheng","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB254","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00093-2","article-title":"Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells","volume":"87","author":"Zhang","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB255","doi-asserted-by":"crossref","first-page":"C913","DOI":"10.1152\/ajpcell.1990.258.5.C913","article-title":"Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells","volume":"258","author":"Lobaugh","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB256","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjp.0701808","article-title":"Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane","volume":"124","author":"Fabi","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB257","first-page":"H1878","article-title":"Neuropeptide Y reduces macromolecule permeability of coronary endothelial monolayers","volume":"271","author":"Noll","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB258","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0196-9781(01)00340-0","article-title":"Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding","volume":"22","author":"Ghersi","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/S0009-8981(02)00301-7_BIB259","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1164\/ajrccm.160.5.9902102","article-title":"Functional effects of neuropeptide Y receptors on blood flow and nitric oxide levels in the human nose","volume":"160","author":"Cervin","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB260","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0091-6749(96)70095-7","article-title":"Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients","volume":"98","author":"Lacroix","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB261","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1152\/jappl.1992.73.5.1867","article-title":"Neuropeptide Y is a vasoconstrictor in human nasal mucosa","volume":"73","author":"Baraniuk","year":"1992","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/S0009-8981(02)00301-7_BIB262","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1476-5381.1994.tb17014.x","article-title":"Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor","volume":"113","author":"Lacroix","year":"1994","journal-title":"Br. J. Pharmacol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898102003017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898102003017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:32:06Z","timestamp":1622248326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898102003017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":262,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S0009898102003017"],"URL":"https:\/\/doi.org\/10.1016\/s0009-8981(02)00301-7","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}